	Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies. Curr Oncol Rep LaGalbo S, Foley MT, Metropulos AE, Burton KA, Principe DR. PMID: 42307813 [PubMed - indexed for MEDLINE]
	Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia. Front Med (Lausanne) Liu CL, Yan FL, Li XL. PMID: 42305964 [PubMed]
	From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia. Front Immunol Rasouli M, Dalem M, Raaijmakers MHGP, Katsikis PD, Erkeland SJ. PMID: 42305542 [PubMed - indexed for MEDLINE]
	Beyond traditional survival estimates: conditional survival and individualized prognosis in primary breast lymphoma. Transl Cancer Res Zhang H, Wu G, Liao C. PMID: 42305490 [PubMed]
	Mogamulizumab for adult T-cell leukemia/lymphoma: a literature review. Transl Cancer Res Jones C, Wang JC, Saeed H. PMID: 42305457 [PubMed]
	Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis. Transl Cancer Res Huang L, Chen K, Wang M, Guo C, Li Y, Yu Q, Liu Z, Li Z. PMID: 42305450 [PubMed]
	Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) inÂ 1st Line Mantle Cell Lymphoma. Am J Hematol Smith SD, Sundaram S, Giri S, Ness A, Wang Y, Gopal AK, Pang Y, Tatoian ET, Grossfeld T, Lynch RC, Warren EH, Nowakowski GS, Park SI. PMID: 42305039 [PubMed - as supplied by publisher]
	Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study. Br J Haematol Ceriani L, Milan L, Cascione L, Di Rocco A, Kryachok I, Davies AJ, Stathis A, Rossi D, Johnson PWM, Martelli M, Zucca E. PMID: 42304704 [PubMed - as supplied by publisher]
	Cost-effectiveness analysis of PET-guided BrECADD with chemotherapy in advanced-stage, classical Hodgkin lymphoma. Cost Eff Resour Alloc Zeng G, Cai B, Zhang H, Liu Y, Li H. PMID: 42304371 [PubMed - as supplied by publisher]
	Long-term oral and dental effects in childhood acute lymphoblastic leukemia survivors: a cross-sectional study comparing early and late post-treatment periods. BMC Oral Health Güney SE, K, K, Ören H, Bulut G. PMID: 42304316 [PubMed - as supplied by publisher]
	Comparative assessment of asparaginase activity, population pharmacokinetics, and safety of biosimilar native Escherichia coli and pegylated asparaginase in children with newly diagnosed acute lymphoblastic leukemia: a pharmacometrics-based randomized clinical trial. BMC Cancer Sethuramalingam S, Mohapatra S, Agarwal PK, Kumar-M P, Hota D, Gopal J, Kulkarni A, Srinivasan A. PMID: 42304309 [PubMed - as supplied by publisher]
	Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort Study. JMIR Res Protoc Asbroek LJ, van der Pal HJ, Fiocco M, Feijen EA, Grundeken LH, Koopman MM, van Litsenburg RR, van der Torre P, Westerink J, Kremer LC, Pluijm SM, Bresters D. PMID: 42302269 [PubMed - indexed for MEDLINE]
	Hematologic Malignancies of Primary Bone Marrow Origin in Adults: The Incidence and Profile in Eleven Years From One National Tertiary Referral Hospital in Indonesia. Cancer Control Hardianti MS, Ratnaningsih T, Muyasarah K, Bintoro BS, Tazkiya I, Hanifah W, Fatimah RGN, Oktariani S, Taroeno-Hariadi KW. PMID: 42302195 [PubMed - indexed for MEDLINE]
	Bilateral primary diffuse large B-cell lymphoma of the breast: diagnostic and surgical management-a case report. Gland Surg Hao Z, Zheng M, Zhang B. PMID: 42299268 [PubMed]
	Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics. Nucleic Acid Ther Hosseinpour B, O'Grady J, Mohaghegh N, Hamati J, McConnell EM, Willmore WG, Hassani Najafabadi A, DeRosa MC. PMID: 42298965 [PubMed - as supplied by publisher]
	Risk of thromboembolic events in patients with polycythaemia vera: a study based on german health claims data. Ann Hematol Manz KC, Morouj B, Feuerbach M, Ehneß R, Lenti P, Barnstorf I, Höer A, Al-Ali HK. PMID: 42298215 [PubMed - indexed for MEDLINE]
	Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial. Int J Clin Oncol Maruyama D, Goto H, Kumode T, Aizawa K, Fukuhara N, Westin JR, Kim WS, Mori C, Imaizumi T, Kato K. PMID: 42298056 [PubMed - as supplied by publisher]
	Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study. Leukemia Renders S, Ngoya M, de Leval L, Finel H, Khvedelidze I, Pocock R, Ram R, Gedde-Dahl T, Serroukh Y, Bug G, Kröger N, Nagler A, Pabst T, Rabitsch W, Yakoub-Agha I, Eder M, Ratip S, Scheid C, Pérez-Simón JA, Wagner-Drouet EM, Sureda A, Schmitz N, Glass B, Bazarbachi A, Dreger P. PMID: 42297918 [PubMed - as supplied by publisher]
	Can natural killer cells cure leukemia? Leukemia Cichocki F, Felices M, Matson AW, Lee MJ, Miller JS. PMID: 42297917 [PubMed - as supplied by publisher]
	Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial. Nat Commun Zou Q, Bai S, Wang L, Tong H, Zeng D, Zhao Y, Shuang Y, Wang X, Sun X, Hong Z, Peng Z, Yang Y, Zheng R, Huang H, Liu J, Yang C, Li X, Gao X, Xu H, Chen D, Fang X, Nie M, Wang J, Gao X, Ye J, Zhang W, Shen J, Tao R, Cen H, Zhang Y, Cai J, Xia Y, Cai Q. PMID: 42297808 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168348

Page 1 of 8418



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy